Transfusion in Gastrointestinal Bleeding

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

936

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

August 31, 2013

Conditions
Gastrointestinal Hemorrhage
Interventions
OTHER

Restrictive transfusion policy

Participants allocated to this group will be eligible for transfusion once their Hb level is ≤ 8 g/dL after presentation to hospital. The objective for the attending clinician is to maintain the Hb level between 8.1-10 g/dL for the duration of hospital stay.

OTHER

Liberal Transfusion Policy

Participants allocated to this group will be eligible for transfusion once their Hb level is ≤ 10 g/dL after presentation to hospital. The objective for the attending clinician is to maintain the Hb level between 10.1-12 g/dL for the duration of hospital stay.

Trial Locations (1)

Unknown

NHSBT Clinical Studies Unit, Oxford

All Listed Sponsors
collaborator

NHS Blood and Transplant

OTHER_GOV

lead

Dr Vipul Jairath

OTHER_GOV

NCT02105532 - Transfusion in Gastrointestinal Bleeding | Biotech Hunter | Biotech Hunter